Literature DB >> 14508254

Alterations in conjunctival cytology and tear film dysfunction in patients with beta-thalassemia.

S P Gartaganis1, C D Georgakopoulos, A Exarchou, E K Mela, C Psachoulia, M I Eliopoulou, A Kourakli, S S Gotsis, R C Tripathi.   

Abstract

PURPOSE: Patients with beta-thalassemia (beta-tha) represent a group with lifelong transfusion-dependent anemias. This study aimed to describe the conjunctival changes and tear film parameters in these patients.
METHODS: A total of 52 patients (104 eyes) with beta-tha major and 22 normal control subjects (44 eyes) were studied during 1999 through 2000. Tear film break-up time (BUT), Schirmer test, rose Bengal staining, and cytologic evaluation of the conjunctival epithelium were performed in all subjects. The Papanicolaou and May-Grümwald-Giemsa staining procedures were performed on all smears. Patients and control subjects were compared for tear function parameters and conjunctival changes.
RESULTS: The BUT, Schirmer test, and rose Bengal staining values were significantly lower (P < 0.001) in beta-tha patients than in control subjects. Keratinized cells were observed in conjunctival samples in 41% of patients, with a decrease in the number of goblet cells per slide in 64% of patients. In 9% of beta-tha patients, there were a slightly greater number of inflammatory cells than in control eyes.
CONCLUSION: Ocular surface disorder of these patients was characterized by goblet cell loss and conjunctival squamous metaplasia. Our findings were correlated positively with the variable age. Epithelial damage by toxic reaction and disorder of tear quality and quantity are implicated as important factors in the pathogenesis of the ocular surface disease in beta-tha patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14508254     DOI: 10.1097/00003226-200310000-00002

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  Ocular findings in children with thalassemia major in Eastern Mediterranean.

Authors:  Adnan Aksoy; Murat Aslankurt; Lokman Aslan; Ozlem Gül; Mesut Garipardıç; Oğuz Celik; Seydi Okumuş; Murat Ozdemir; Gökhan Ozdemir
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

Review 2.  Ocular abnormalities in beta thalassemia patients: prevalence, impact, and management strategies.

Authors:  Samira Heydarian; Reza Jafari; Kiumars Nowroozpoor Dailami; Hassan Hashemi; Ebrahim Jafarzadehpour; Mohsen Heirani; Abbasali Yekta; Monireh Mahjoob; Mehdi Khabazkhoob
Journal:  Int Ophthalmol       Date:  2019-10-10       Impact factor: 2.031

3.  Ocular manifestations in patients with transfusion-dependent β-thalassemia.

Authors:  F Akritidou; A Praidou; T Papamitsou; V Kozobolis; G Labiris
Journal:  Hippokratia       Date:  2021 Apr-Jun       Impact factor: 0.522

Review 4.  β-Thalassemia and ocular implications: a systematic review.

Authors:  Aliki Liaska; Petros Petrou; Constantinos D Georgakopoulos; Ramza Diamanti; Dimitris Papaconstantinou; Menelaos G Kanakis; Ilias Georgalas
Journal:  BMC Ophthalmol       Date:  2016-07-08       Impact factor: 2.209

5.  Anterior Chamber Angle, Intraocular Pressure, and Globe Biometric Parameters in the Children with β-Thalassemia Major.

Authors:  Nermien Sm El-Haddad
Journal:  J Curr Glaucoma Pract       Date:  2020 Jan-Apr

6.  Evaluation of Corneal Epithelial Thickness and Dry Eye Disease Tests in Thalassemic Adolescents.

Authors:  Weam Mohamed Ebeid; Mahmoud Adel Kenny; Tamer AbdelFattah Badran
Journal:  Clin Ophthalmol       Date:  2021-04-06

7.  Ocular abnormalities in multi-transfused beta-thalassemia patients.

Authors:  Reza Jafari; Samira Heydarian; Hosein Karami; Mohammad Momeni Shektaei; Kiumars Noruzpour Dailami; Ahmad Ahmadzadeh Amiri; Majid Reza Sheikh Rezaee; Asad Allah Farrokh Far
Journal:  Indian J Ophthalmol       Date:  2015-09       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.